DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Daniele G, Lorusso D, Scambia G. et al.
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Gynecol Oncol 2017;
144: 256-259
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.